DexCom (NASDAQ: DXCM) reported Q2 EPS of ($0.24), $0.12 worse than the analyst estimate of ($0.12). Revenue for the quarter came in at $137.3 million versus the consensus estimate of $132.59 million.

For earnings history and earnings-related data on DexCom (DXCM) click here.